Will global transcriptome analysis allow the detection of novel prognostic markers in coronary artery disease and heart failure?

PubWeight™: 0.76‹?›

🔗 View Article (PMC 3861890)

Published in Curr Genomics on September 01, 2013

Authors

Monika Gora1, Marek Kiliszek2, Beata Burzynska1

Author Affiliations

1: Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland;
2: First Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Articles cited by this

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J (2012) 18.18

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J (2012) 16.00

Progress and challenges in translating the biology of atherosclerosis. Nature (2011) 9.41

Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59

Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation (2003) 8.29

Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med (2013) 5.43

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation (2003) 4.31

Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ (2006) 4.18

Altered patterns of gene expression in response to myocardial infarction. Circ Res (2000) 2.76

C-reactive protein and coronary heart disease: a critical review. J Intern Med (2008) 2.25

Transcriptome analysis using next-generation sequencing. Curr Opin Biotechnol (2012) 1.97

Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis. Circ Cardiovasc Genet (2008) 1.92

The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol Med (2007) 1.91

Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J (2010) 1.88

Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure. Circ Cardiovasc Genet (2011) 1.68

Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation (2003) 1.66

PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol (2008) 1.63

Molecular dynamics of the compensatory response to myocardial infarct. J Mol Cell Cardiol (2004) 1.63

Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases. Int J Cardiol (2011) 1.62

A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart. J Clin Invest (2007) 1.61

Mixed messages: transcription patterns in failing and recovering human myocardium. Circ Res (2005) 1.61

Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol Genomics (2005) 1.54

Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation (2004) 1.47

Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease. PLoS One (2009) 1.45

Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J (2011) 1.42

Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure. Circulation (2010) 1.28

The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines. Clin Chem (2008) 1.25

Biomarkers in acute myocardial infarction. BMC Med (2010) 1.22

Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci (Lond) (2010) 1.17

Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure. Eur J Heart Fail (2006) 1.12

Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. Circulation (2000) 1.09

Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genomics (2009) 1.07

Global gene expression profiling in the failing myocardium. Circ J (2009) 1.04

Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction. Circulation (2001) 1.03

Identification of genes related to heart failure using global gene expression profiling of human failing myocardium. Biochem Biophys Res Commun (2010) 1.01

Animal models of dilated cardiomyopathy for translational research. Vet Res Commun (2007) 0.97

Altered gene expression pattern in peripheral blood mononuclear cells in patients with acute myocardial infarction. PLoS One (2012) 0.95

Aetiology-specific patterns in end-stage heart failure patients identified by functional annotation and classification of microarray data. Eur J Heart Fail (2006) 0.93

Genetic basis for chamber-specific ventricular phenotypes in the rat infarct model. Cardiovasc Res (2003) 0.92

Molecular signatures of end-stage heart failure. J Card Fail (2011) 0.92

Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. Cardiovasc Res (2002) 0.91

Blood gene expression signatures associate with heart failure outcomes. Physiol Genomics (2011) 0.91

Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction. Funct Integr Genomics (2010) 0.90

A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels. J Intern Med (2007) 0.89

Distinct molecular portraits of human failing hearts identified by dedicated cDNA microarrays. Eur J Heart Fail (2005) 0.87

Pathological and physiological hypertrophies are regulated by distinct gene programs. Eur J Cardiovasc Prev Rehabil (2009) 0.87

Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach. Physiol Genomics (2003) 0.86

Genomic analysis reveals poor separation of human cardiomyopathies of ischemic and nonischemic etiologies. Physiol Genomics (2008) 0.86

Molecular risk stratification in advanced heart failure patients. J Cell Mol Med (2009) 0.85

Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction. BMC Med Genomics (2011) 0.84

An introduction to genes, genomes and disease. J Pathol (2010) 0.81

Gene expression profiling and its practice in drug development. Curr Genomics (2007) 0.78

Transcriptomic biomarkers of the response of hospitalized geriatric patients admitted with heart failure. Comparison to hospitalized geriatric patients with infectious diseases or hip fracture. Mech Ageing Dev (2011) 0.77

N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome. Clin Sci (Lond) (2009) 0.77

Heart failure transcriptome: when discoveries change practice? Circ Cardiovasc Genet (2011) 0.76